Dr. Wendy Spettigue was the Psychiatric Director of the Regional Eating Disorder Program at CHEO from 2001-2013. She completed her residency training at Queen’s University in Pediatrics and Psychiatry, and moved with her family to Ottawa in 1999 to do a Fellowship in pediatric consultation-liaison psychiatry and eating disorders. As part of her clinical work, Dr. Spettigue provides individual, group and family therapy to adolescents with severe eating disorders. Dr. Spettigue is also involved in various research projects. She was the recipient of the CHEO Research Institute’s 2009 Award of Excellence for Research in Psychiatry.
The impact of COVID-19 on adolescents with eating disorders: a cohort study
Further research is required to better understand the impact of the pandemic on the clinical course and outcomes of EDs in adolescents.
Characteristics and clinical trajectories of patients meeting criteria for avoidant/restrictive food intake disorder that are subsequently reclassified as anorexia nervosa
Prospective longitudinal research that utilizes ARFID‐specific as well as traditional eating disorder diagnostic measures is required to better understand how patients with restrictive eating disorders that deny fear of weight gain can be differentiated and best treated.
Development of the Ottawa Disordered Eating Screen for Youth: The ODES-Y
Our findings suggest that the index test has utility as a short and accurate screening tool for earlier detection of disordered eating thoughts and behaviors in youth.
Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review
CY appears to be a safe, generally well-tolerated medication that has utility in helping facilitate weight gain in patients drawn from a variety of underweight populations. Future prospective randomized controlled studies in low weight patients that include objective measures of appetite and intake are needed to better understand the mechanism by which CY augments weight gain.